Skip to primary content
Skip to secondary content

gutsandgrowth

Pediatric Gastroenterology

gutsandgrowth

Main menu

  • Home
  • About Jay Hochman -Pediatric Gastroenterology Blog

Tag Archives: inflammatory bowel disease diet

UVA Links

Posted on January 21, 2013 by gutsandgrowth

My alma mater, the University of Virginia, has a fair amount of useful GI educational material on their website.

Here are a few links:

Low FODMAP Diet

Irritable Bowel Syndrome (IBS) diet

Short Bowel Syndrome Diet (Long Version)

Nutritional Considerations for Patients with Inflammatory Bowel Disease

Fiber (dietary recommendations handout)

Gluten-free Diet

Posted in Gastroenterology | Tagged fiber, FODMAP diet, gluten free diet, inflammatory bowel disease diet, irritable bowel syndrome, short bowel syndrome diet

Categories

Enter your email address to follow this blog and receive notifications of new posts by email.

Top Posts & Pages

  • Get Ready for 2021 Coding Changes
  • Dupilumab Rarely Associated with Pediatric Neuroinflammatory and Neuropsychiatric Symptoms
  • GI Bleeding -Forrest Classification
  • Expert Practice Recommendations for C difficile Infection in Adults
  • More Data Supporting Lactated Ringers for Acute Pancreatitis
  • Incredible Video of Lung Cell Cilia
  • Review: Infectious Esophagitis
  • Pictographic Constipation Action Plan
  • How to Score the Ulcerative Colitis Endoscopic Index of Severity (UCEIS) Properly
  • Safe Baby Formula Choices Based on Consumer Reports Testing

Log-In

  • Create account
  • Log in
  • Entries feed
  • Comments feed
  • WordPress.com

Recent Posts

  • Expert Practice Recommendations for C difficile Infection in Adults
  • Dupilumab Rarely Associated with Pediatric Neuroinflammatory and Neuropsychiatric Symptoms
  • Incredible Video of Lung Cell Cilia
  • Adherence to a Gluten Free Diet in Pediatric Celiac Disease
  • Promising Pilot Study Using Substance P to Screen for Pediatric Aspiration
  • Impact of Night Shifts on Gut Disorders
  • PODIUM Study: Jak Inhibitors and Ustekinumab Outperformed Vedolizumab as a 2nd Line Agent for Ulcerative Colitis
Blog at WordPress.com.
  • Subscribe Subscribed
    gutsandgrowth
    Join 1,031 other subscribers

    Have a WordPress.com account? Log in now.

  • gutsandgrowth
    View site in Reader
    Manage subscriptionsSign upLog in
    Report this content
    Collapse this bar